SEC Form 4 · accession 0001179110-15-007265
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin E Lofton
Director
Period of report
May 6, 2015
Accepted (ET)
May 7, 2015 · 5:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F3 | — | May 6, 2015 | A | 1,466 | A | — | — | Common Stock | 1,466 | 3,370 | D |
| Non-Qualified Stock Options (Right to Buy)F1 | $102.27 | May 6, 2015 | A | 5,167 | A | — | May 6, 2025 | Common Stock | 5,167 | 5,167 | D |
Explanation of responses
- F1Options vest quarterly over the first year of service upon the earlier of May 6, 2016, or the day immediately preceding the next regular annual stockholders meeting.
- F2Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- F3100% of the restricted stock units will vest upon the earlier of May 6, 2016, or the day immediately preceding the next regular annual stockholders meeting.